Syneos Health Inc (SYNH) Return on Assets ROA from the second quarter of 2023 to second quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket
 


Syneos Health Inc   (NASDAQ: SYNH)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Syneos Health Inc 's ROA from the second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Syneos Health Inc 's ROA in the second quarter of 2023?
Syneos Health Inc achieved a return on average assets (ROA) of 0.88 % in its second quarter of 2023, which is below Syneos Health Inc 's average return on assets, which stands at 2.52%.

ROA fell compared to the first quarter of 2023, despite the net income growth of % from the first quarter of 2023.

However, within the Healthcare sector 200 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2023 from 2095 to 2532.

What is ROA?



Return On Assets (Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Total Assets Change -2.01 % -2.65 % -0.82 % -0.13 % 2.52 %
Y / Y Net Income Change -98.98 % - -26.9 % 11.25 % 85.52 %
Net Income (TTM) in million 71 148 266 287 278
Return On Assets (TTM) 0.88 % 1.82 % 3.25 % 3.49 % 3.39 %
SYNH's Total Ranking # 2532 # 2095 # 2098 # 1819 # 1959
Total Assets (TTM) in million 8,020 8,052 8,152 8,169 8,185
Seq. Total Assets Change -0.39 % -1.22 % -0.21 % -0.2 % -1.04 %
Seq. Net Income Change - - -36.21 % 11.97 % 68.36 %



Return On Assets Company Ranking
Within: No.
Industry # 10
Sector # 201
Overall # 2496

Return On Assets Statistics
High Average Low
9.35 %
2.52 %
-4.51 %
(Dec 31 2015)   (Jun 30 2015)





Financial Statements
Syneos Health Inc 's Assets $ 8,020 million SYNH's Balance sheet
Syneos Health Inc 's Income $ 1 million Quarterly SYNH's Income Statement
SYNH's Income by Division See SYNH's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021
(Dec 31 2020)
FY 2020
(Dec 31 2019)
FY 2019
(Dec 31 2018)
FY 2018
Y / Y Total Assets Change -0.63 % 2.17 % 7.72 % 2.74 % -0.42 %
Total Assets in million 8,152 8,203 8,029 7,454 7,255
Y / Y Net Income Change 13.48 % 21.81 % 46.88 % 440.51 % -
Net Income in million 266 235 193 131 24
Annual Return On Assets 3.27 % 2.86 % 2.4 % 1.76 % 0.33 %




Comment on SYNH's ROA in the fiscal year ending 2022
In the fiscal year 2022 ROA improved to 3.27 % compared to prior year, due to annual net income growth of 13.48 % to $266.50 million, and due to decline of value in Syneos Health Inc 's assets by -0.63 % to $8,151.61 million, compared to $8,151.61 a year before.


More Return On Assets Ratios
SYNH's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SYNH's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SYNH's Competitors
Subscribers only: Roa for Syneos Health Inc 's Suppliers
Subscribers only: Return On Assets for SYNH's Customers

You may also want to know
SYNH's Roi SYNH's Inventory Turnover Ratio SYNH's Growth Rates SYNH's Dividend Comparisons
SYNH's Profitability Ratios SYNH's Asset Turnover Ratio SYNH's Dividend Growth
SYNH's Roe SYNH's Valuation Ratios SYNH's Financial Strength Ratios SYNH's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2023, within Healthcare Sector ROA
Zimmer Biomet Holdings Inc   2.39 %
The Cooper Companies Inc   2.38 %
Vanda Pharmaceuticals Inc   2.34 %
National Healthcare Corp  2.32 %
Organogenesis Holdings Inc   2.23 %
Inmed Pharmaceuticals Inc  2.13 %
Penumbra Inc  2.11 %
Futuretech Ii Acquisition Corp   2.10 %
Atlantic Coastal Acquisition Corp Ii  2.05 %
Blueriver Acquisition Corp  1.89 %
Dih Holding Us Inc   1.57 %
Biomarin Pharmaceutical Inc  1.56 %
Viskase Holdings inc   1.49 %
Surgery Partners Inc   1.33 %
Nuvasive Inc  1.31 %
American Shared Hospital Services  1.24 %
10x Capital Venture Acquisition Corp Iii  1.22 %
National Vision Holdings Inc   1.13 %
Steris Plc  1.11 %
Adapthealth Corp   0.90 %
Syneos Health Inc   0.87 %
Sbc Medical Group Holdings Incorporated  0.85 %
Cdt Equity Inc   0.68 %
Infusystem Holdings Inc  0.66 %
Perrigo Company Plc  0.65 %
Msa Safety Inc  0.58 %
Quidelortho Corp  0.52 %
Radnet Inc   0.48 %
Nevro Corp   0.44 %
Orthopediatrics Corp  0.23 %


Date modified: 2026-09-08T15:11:01+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.